Comparative Analgesia and Respiratory Effects of Shoulder Blocks
Analgesic Efficacy and Respiratory Effects of Interscalene, Anterior Suprascapular, and Pericapsular Nerve Group Blocks in Shoulder Arthroscopy
1 other identifier
interventional
120
1 country
1
Brief Summary
Interscalene block is widely accepted as the gold-standard regional analgesic technique for pain control after arthroscopic shoulder surgery. However, because this block is performed at the level of the brachial plexus roots, it may be associated with adverse effects such as phrenic nerve blockade and subsequent diaphragmatic dysfunction. These limitations have prompted the search for alternative regional anesthesia techniques that can provide effective postoperative analgesia while preserving respiratory function. The anterior suprascapular block, which covers a broad dermatomal distribution of the shoulder region, has been shown in some studies to provide sufficient analgesia as a standalone technique. In addition, the pericapsular nerve group (PENG) block of the shoulder-applied around the anterior capsule and performed at a distance from critical neurovascular structures that may lead to serious complications-may represent another potential analgesic option following arthroscopic shoulder procedures. Therefore, this study aims to evaluate alternative regional block techniques in comparison with the interscalene block and to contribute to the identification of an optimal analgesic strategy after arthroscopic shoulder surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable postoperative-pain
Started Feb 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 13, 2026
CompletedStudy Start
First participant enrolled
February 23, 2026
CompletedFirst Posted
Study publicly available on registry
February 24, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 10, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2026
February 24, 2026
February 1, 2026
9 months
February 13, 2026
February 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain scores
Pain will be assessed at rest and while coughing using the visual analog scale on a scale from 0 (no pain) to 100 (worst pain) at the first postoperative hour.
First hour after the surgery
Secondary Outcomes (4)
Pain scores
First 24 hours after surgery
Forced vital capacity (FVC) (volume)
Perioperative period
Forced expiratory flow in 1 s (FEV1) (volume)
Perioperative period
FEV1/FVC
Perioperative period
Study Arms (3)
Interscalene block
ACTIVE COMPARATORIn the preoperative period, 10 mL of 0.25% bupivacaine will be injected between C5 and C6 using an in-plane technique guided by a linear ultrasound (US) probe.
Anterior suprascapular block
ACTIVE COMPARATORA linear ultrasound probe will be positioned in the supraclavicular fossa, parallel to the clavicle. The suprascapular nerve will be identified as a hyperechoic oval structure deep to the omohyoid muscle and posterior-lateral to the brachial plexus. 10 mL of local anesthetic will be injected under the omohyoid muscle, around the suprascapular nerve.
Pericapsular nerve group (PENG) block
ACTIVE COMPARATORA linear ultrasound probe will be placed sagittally, near the axillary region, just below the coracoid process. The subscapularis muscle and its tendon will be visualized. The target area is the space between the deep fascia of the subscapularis muscle and the anterior surface of the shoulder joint capsule. The needle will pass the subscapularis muscle and be guided into the plane between the capsule and the muscle, where 20 mL of local anesthetic will be dispensed to block the articular branches innervating the capsule.
Interventions
Interscalene block will be performed, under US guidance, before the surgical operation, and when the patient is placed in the supine position.
Anterior suprascapular block will be performed, under US guidance, before the surgical operation, and when the patient is placed in the supine position.
Pericapsular nerve group (PENG) block will be performed, under US guidance, before the surgical operation, and when the patient is placed in the supine position.
Eligibility Criteria
You may qualify if:
- Patients with ASA scores I-II-III
- Patients scheduled for elective arthroscopic shoulder surgery
- Patients who have been informed about the study and have given written consent will be included.
You may not qualify if:
- Those with a known allergy to local anesthetics
- Those with an infection at the application site
- Those with a severe coagulopathy disorder or anticoagulant use
- Those with contralateral phrenic nerve palsy or a serious pulmonary diagnosis
- Those with a history of chronic opioid use or neuropathic pain
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara Etlik City Hospital
Yenimahalle, Ankara, 06170, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal İnvestigator
Study Record Dates
First Submitted
February 13, 2026
First Posted
February 24, 2026
Study Start
February 23, 2026
Primary Completion (Estimated)
November 10, 2026
Study Completion (Estimated)
November 30, 2026
Last Updated
February 24, 2026
Record last verified: 2026-02